Search Tag: CVD
2019 01 Aug
The prevalence of Type 2 diabetes has become a public health issue, as the International Diabetes Federation recorded a total of 425 million adults between the ages of 20 and 79 that had diabetes in 2017. The main cause of disability and mortality in this cohort is due to issues involving cardiovascular health. The American Heart Association has now...Read more
2019 25 Jul
The benefits of low-dosages of aspirin (75-100mg daily) for the secondary prevention of cardiovascular diseases (CVDs) exceed the risk of bleeding. However, most are still unclear whether aspirin has the same effects on primary prevention. The recent results from three trials ASPREE, ASCEND and ARRIVE each tested the effects of 100mg of aspirin...Read more
2019 20 Mar
An updated guideline for the primary prevention of cardiovascular disease has been released jointly by the American Heart Association (AHA) and the American College of Cardiology. Among the major changes is a recommendation against the broad use of aspirin in primary prevention, after recently reported results of the ARRIVE, ASCEND, and ASPREE trials...Read more
2019 16 Jan
The use of multivitamin/mineral supplements is quite high in the US and other developed countries. There is a widespread belief that MVM supplementation has a positive effect on cardiovascular health. Several clinical studies have been conducted to identify the association between multivitamin/mineral (MVM) supplementation and cardiovascular...Read more
2018 22 Sep
Jacobs Institute idea to Reality (i2R) Centre addresses major health crisis. A medical innovation centre shows how a one-stop-shop approach to CVD medical device creation is accelerating impactful results for all stakeholders. There is a global health crisis in cardiovascular disease that will require out-of-the-box thinking, collaborations,...Read more
2017 08 Aug
Obesity is considered a risk factor for cardiovascular diseases (CVD). There is evidence that the entire spectrum of CVD is increased in obesity, including coronary heart disease, stroke, hypertension, heart failure, peripheral vascular disease, arrhythmias, and atrial fibrillation. Interestingly, it's also known that obese patients with established...Read more
2017 18 May
According to a new study, cardiovascular diseases, including heart diseases and stroke, account for nearly one-third of deaths throughout the world. The study examined all countries over the last 25 years. The paper titled Global, Regional, and National Burden of Cardiovascular Diseases for10 Causes, 1990-2015, is published in the Journal of the American...Read more
2017 07 Feb
Observational data and biological plausibility suggest a relationship between insomnia and cardiovascular disease (CVD), but little is known about how treatment of insomnia may impact CVD, and causality is difficult to ascertain from observational studies, according to a review to appear in CHEST Journal. The researchers emphasise the need for randomised...Read more
2016 25 Aug
Interview with Professor Guy de Backer Professor Guy De Backer, Emeritus Professor at Ghent University, Belgium, will be a keynote speaker at the ESC Conference in Rome on August 27-31, delivering the ESC Geoffrey Rose Lecture on Population Sciences on “Epidemiology and Prevention of Cardiovascular Diseases: Quo Vadis?” Prior to the conference,...Read more
2016 23 Aug
New data published in Heart reveal that deaths from heart disease and stroke have declined by almost 70 percent in the UK over the past 30 years. However, these improvements are not equally distributed among all four countries or between men and women. The prevalence of cardiovascular disease has not budged and drug and surgical treatments over...Read more
2016 16 Aug
Despite cancer accounting for less than half the number of deaths than CVD in Europe as a whole, in nine of the 15 countries which were members of the European Union before 2004 (EU-15) and in another country that was among those that joined the EU afterwards (EU-28), more men now die from cancer than CVD. These countries are: Belgium, Denmark,...Read more
2016 04 Jun
The World Heart Federation is dedicated to leading the global fight against cardiovascular disease (CVD) – including heart disease and stroke - with a focus on low- and middle-income countries, via a united community of more than 200 member organizations . It aligns its efforts around the World Health Organization’s related target of reducing premature...Read more
2016 08 Jul
The Frontiers in CardioVascular Biology meetings are increasingly considered as one of the most relevant exchange platforms for basic and translational cardiovascular biology. Our Programme is designed to be cross-disciplinary, both between and within sessions, to emphasise underlying scientific developments important to cardiovascular biology.Read more
2016 05 May
DUE TO SECURITY CONCERN THIS EVENT GOT CANCELLED Welcome to EuroPRevent 2016, the European Association for Cardiovascular Prevention and Rehabilitation’s ( EACPR ) showcase congress, where leading experts will get together in an international forum to present their research and share knowledge. Join us in the stunning city of Istanbul...Read more
2015 04 Dec
A large, long-term study conducted with a racially diverse group of adults in the U.S. found that cardiorespiratory fitness (CRF) in young adults is associated with a lower risk of cardiovascular disease (CVD) and death. However, no association was found with the development of coronary artery calcification. The findings are published in JAMA Internal...Read more
2015 17 Sep
Siemens Healthcare is providing simple tools and advanced technology to help tackle the perception that cardiac MR is complex and unobtainable for widespread use. A range of innovative technology from Siemens Healthcare ensures the most difficult cardiac MR examinations can be simplified Tackles misconceptions around cardiac...Read more
2015 27 Jul
During the upcoming ESC Congress 2015, six hot line sessions are expected to reveal the latest in cardiovascular research. Some of the hot topics that are to be covered include atrial fibrillation, pacing, acute myocardial infarction, heart failure, hypertension, diabetes mellitus, pharmacology and coronary artery disease. Professor Genevieve Derumeaux,...Read more
2015 16 Jul
According to a study published in JAMA , the 2013 cholesterol guidelines for determining statin eligibility are more accurate and efficient in identifying increased risk of cardiovascular disease events and presence of subclinical coronary artery disease as compared to guidelines from 2004. The 2013 guidelines from the American College of Cardiology...Read more
2015 14 Apr
The impact of industrially produced trans fatty acids (TFAs) on the health of citizens in the European Union (EU) will be debated today by Members of the European Parliament (MEPs), representatives of the European Commission and WHO Europe. The panel debate, which takes place in the European Parliament, Brussels is an initiative of the Members of the...Read more
2015 06 Mar
CVD is the top cause of death in women in Europe Cardiovascular disease (CVD) kills 51% of women in Europe and breast cancer kills 3%, bucking the misperception that CVD is a man’s disease. CVD is the top killer in women and is largely preventable. The call for women to reduce their risk comes from the European Society of Cardiology (ESC) on International...Read more
2015 10 Feb
Researchers have found that blood pressure (BP)-lowering treatment among patients with type 2 diabetes mellitus is associated with a lower risk of cardiovascular disease (CVD) and heart disease events and improved mortality. They noted that each 10-mm Hg lower systolic BP was associated with a lower risk of mortality, CVD events, coronary heart disease...Read more
2015 04 Feb
Researchers have found that sustained isolated systolic hypertension (ISH) in young and middle-aged adults increased their risk of dying from cardiovascular causes later in life. ISH is defined as systolic blood pressure greater than or equal to 140 mm Hg when diastolic blood pressure is less than 90 mm Hg. Their analysis based on outcomes from 18-...Read more
2015 21 Jan
A study which appears in the January 20 issue of JAMA claims that the hospitalisation of older adults with pneumonia is associated with increased short and long-term cardiovascular disease (CVD) risk, and suggests that pneumonia is an important risk factor for CVD. Pneumonia affects 1.2 percent of the northern hemisphere's population each year, and...Read more
2015 16 Jan
New research from Montreal Heart Institute (MHI) has found that cardiovascular patients with a specific genetic profile benefit greatly from the new medication dalcetrapib. The drug reduced heart attacks, strokes, unstable angina, coronary revascularisations and cardiovascular deaths by as much as 39 percent. The findings could pave the way for a new...Read more
2015 13 Jan
According to a new study published in The Lancet , statin treatment reduces the risk of cardiovascular disease in women. There has been much debate about the effectiveness of statin therapy in women as compared to men, especially when used for primary prevention. This particular study compares the effects of statin therapy between men and women....Read more
2014 25 Sep
As part of its work to implement actions from the Cardiovascular Disease (CVD) Outcomes Strategy, the Living Longer Lives programme at NHS Improving Quality is launching a pilot study that aims to identify and prevent cardiovascular disease in people with serious mental illness, ultimately saving lives. The Living Longer Lives team at NHS improving...Read more
2014 19 Sep
Cardiovascular disease (CVD) - a grouping of diseases that affects the structure and/or function of the heart and blood vessels, including heart disease and stroke - is the number 1 killer in Europe claiming over 4 million lives in the Europe and 1.9 million lives per year in the European Union (EU). CVD is alsoRead more
2014 24 Jun
Biventricular pacing, also known as cardiac resynchronisation therapy (CRT), is used to improve cardiac rhythm in heart failure patients. Ultimately, CRT can lower the number of hospitalisations and the risk of death in such patients. A new study in JAMA Internal Medicine reveals that women may benefit more than men from CRT-D, in which CRT is combined...Read more
2014 26 Mar
According to a new study published in the March 26 issue of JAMA, which analysed close to 295,000 adults without a known history of diabetes or cardiovascular disease (CVD), the prediction of CVD risk is hardly enhanced when information about glycated hemoglobin (HbA 1c ), a measure of longer-term blood sugar control, is added to conventional CVD...Read more